J2920 – Injection, methylprednisolone sodium succinate, up to 40 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ2920
- Long description
- Injection, methylprednisolone sodium succinate, up to 40 mg
- Short description
- Methylprednisolone injection
- Pricing indicator
51Drugs- Medicare coverage
DSpecial coverage instructions apply- BETOS category
O1EOther drugs- Added
- January 1, 1982
- Last change
- April 1, 2024 – No change
- Termination date
- March 31, 2024
Frequently asked questions
What is HCPCS code J2920?
J2920 is a HCPCS Level II code for injection, methylprednisolone sodium succinate, up to 40 mg. It was discontinued on March 31, 2024.
Does Medicare cover J2920?
The HCPCS file lists coverage code D: Special coverage instructions apply. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J2820 – Injection, sargramostim (gm-csf), 50 mcg
- J2840 – Injection, sebelipase alfa, 1 mg
- J2850 – Injection, secretin, synthetic, human, 1 microgram
- J2860 – Injection, siltuximab, 10 mg
- J2865 – Injection, sulfamethoxazole 5 mg and trimethoprim 1 mg
- J2910 – Injection, aurothioglucose, up to 50 mg
- J2916 – Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg
- J2919 – Injection, methylprednisolone sodium succinate, 5 mg
- J2930 – Injection, methylprednisolone sodium succinate, up to 125 mg
- J2940 – Injection, somatrem, 1 mg
- J2941 – Injection, somatropin, 1 mg
- J2950 – Injection, promazine hcl, up to 25 mg
- J2993 – Injection, reteplase, 18.1 mg
- J2995 – Injection, streptokinase, per 250,000 iu
- J2997 – Injection, alteplase recombinant, 1 mg
- J2998 – Injection, plasminogen, human-tvmh, 1 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.